Over the past decade, there has been a wealth of research investigating the ideal approach to RHD...
Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first...
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
.jpg){kind=logo}
Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc....
-1.png)
On October 26th, we hosted an insightful webinar by Prof. Milan Macek (M.D., DSc.), where he...
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...
Meet Silvia Borras, a Development Lead and Clinical Scientist in Genetics and Molecular Pathology...
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
-1.png)
Dear Devyser network, partners, and valued customers,
